IRIS
BONANNI, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.888
EU - Europa 10.348
AS - Asia 9.193
SA - Sud America 1.473
AF - Africa 155
Continente sconosciuto - Info sul continente non disponibili 23
OC - Oceania 22
Totale 35.102
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.583
SG - Singapore 3.679
CN - Cina 2.406
IT - Italia 2.362
RU - Federazione Russa 1.734
IE - Irlanda 1.345
BR - Brasile 1.167
UA - Ucraina 1.150
VN - Vietnam 932
GB - Regno Unito 855
TR - Turchia 819
SE - Svezia 786
DE - Germania 685
FR - Francia 578
IN - India 446
FI - Finlandia 332
BD - Bangladesh 230
HK - Hong Kong 208
CA - Canada 178
AR - Argentina 107
JP - Giappone 96
NL - Olanda 91
MX - Messico 90
PL - Polonia 86
AT - Austria 67
IQ - Iraq 67
ES - Italia 64
ZA - Sudafrica 64
EC - Ecuador 49
CZ - Repubblica Ceca 48
ID - Indonesia 40
CO - Colombia 36
PK - Pakistan 33
IR - Iran 30
BE - Belgio 29
VE - Venezuela 29
CL - Cile 28
KR - Corea 26
LU - Lussemburgo 26
UZ - Uzbekistan 22
PE - Perù 21
MA - Marocco 20
EU - Europa 19
LT - Lituania 19
JO - Giordania 18
PY - Paraguay 17
SA - Arabia Saudita 17
AE - Emirati Arabi Uniti 16
IL - Israele 16
EG - Egitto 15
RO - Romania 15
AU - Australia 14
CH - Svizzera 13
TN - Tunisia 13
AZ - Azerbaigian 11
DK - Danimarca 11
DZ - Algeria 10
OM - Oman 10
PT - Portogallo 10
DO - Repubblica Dominicana 8
JM - Giamaica 8
LB - Libano 8
MY - Malesia 8
PH - Filippine 8
UY - Uruguay 8
HN - Honduras 7
KE - Kenya 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
BO - Bolivia 6
GR - Grecia 6
SN - Senegal 6
ET - Etiopia 5
KZ - Kazakistan 5
AM - Armenia 4
BG - Bulgaria 4
GY - Guiana 4
HU - Ungheria 4
KH - Cambogia 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
PS - Palestinian Territory 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
AL - Albania 3
CR - Costa Rica 3
KG - Kirghizistan 3
LV - Lettonia 3
SC - Seychelles 3
SM - San Marino 3
TW - Taiwan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BH - Bahrain 2
CY - Cipro 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
QA - Qatar 2
RS - Serbia 2
Totale 35.074
Salva come PNG Salva come JPEG
Città #
Singapore 2.672
San Jose 1.743
Chandler 1.491
Jacksonville 1.342
Dublin 1.322
Ashburn 1.003
Dallas 623
Princeton 621
Beijing 570
Southend 570
Izmir 419
Council Bluffs 418
Nanjing 409
Los Angeles 348
Ho Chi Minh City 304
Santa Clara 293
Dearborn 290
Wilmington 274
New York 250
The Dalles 242
Cambridge 210
Chieti 204
Hanoi 200
Altamura 195
Munich 191
Hong Kong 186
Tongling 159
Ann Arbor 144
Nanchang 139
Buffalo 134
Rome 128
São Paulo 123
Boardman 115
Moscow 114
Pescara 112
Redondo Beach 112
Milan 104
Orem 87
Woodbridge 77
Helsinki 76
Tokyo 72
Tianjin 71
Hebei 69
Washington 68
Warsaw 66
Shenyang 61
Toronto 61
Houston 59
Brooklyn 58
Kunming 57
London 56
Chennai 55
Denver 55
Montreal 54
Turku 54
Frankfurt am Main 53
Nuremberg 51
Hefei 50
Chicago 49
Grevenbroich 49
Atlanta 46
Jiaxing 45
Norwalk 44
Belo Horizonte 42
Changsha 41
Da Nang 41
Seattle 41
Johannesburg 40
Stockholm 40
Haiphong 39
Poplar 38
Hangzhou 36
Jinan 35
Dong Ket 34
Mexico City 33
Amsterdam 32
Florence 32
Manchester 32
San Francisco 32
Phoenix 31
Brno 30
Biên Hòa 28
Vienna 28
Rio de Janeiro 27
Augusta 26
Capurso 26
Naples 25
Boston 24
Falls Church 24
Pune 24
Baghdad 23
Brussels 23
Lanzhou 23
Mumbai 23
New Delhi 23
Paris 23
Hải Dương 22
Leawood 22
Ardabil 21
Seoul 21
Totale 20.422
Salva come PNG Salva come JPEG
Nome #
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 1.153
Emergenza neurologica - tempesta distonica: diagnosi e terapia 499
EDONISMO OMEOSTATICO, COMPLICAZIONE RARA DELLA MALATTIA DI PARKINSON: 10 ANNI DI FOLLOW-UP. 315
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 282
Pre-trattamento antiematico per Test/terapia all'apomorfina 199
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 198
Dropped head syndrome with necrotizing myopathy: A drug class effect confirmed by 3 repeated exposures to non ergolinic dopamine agonists, due to L-Dopa phobia 187
Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases 185
GABA levels in the ventromedial prefrontal cortex during the viewing of appetitive and disgusting food images 181
Le anomalie EEG precoci predicono la comparsa di fluttuazionicognitive nella con demenza. 179
Abnormalities of Cortical Neural Synchronization Mechanisms in Subjects with Mild Cognitive Impairment due to Alzheimer's and Parkinson's Diseases: An EEG Study 176
GABA content within the ventro-medial prefrontal cortex is related to trait anxiety 172
NUOVI MARKER DIAGNOSTICI NELLA DEMENZA A CORPI DI LEWY. 168
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism 167
Akinetic crisis in Dementia with Lewy Bodies 167
Quantitative electroencephalogram utility in predicting conversion of mild cognitive impairment to dementia with Lewy bodies 166
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 164
Ascertainment bias in dementias: a secondary to tertiary centre analysis in Central Italy and conceptual review 163
Functional and neurochemical interactions within the amygdala-medial prefrontal cortex circuit and their relevance to emotional processing 163
Abnormalities of resting-state functional cortical connectivity in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 160
TREMORE PSEUDO - ORTOSTATICO RESPONSIVO ALLA LEVO - DOPA IN PARKINSONISMO. 159
Amyloid B-1-42 stimulated T cells express protein kinase C-delta and/or protein kinase C-Z in Alzheimer disease. 159
Amyloid-specific T-cells differentiate Alzheimer's disease from Lewy body dementia 158
Brainstem Midline Assessed by Transcranial Sonography in Parkinson's Disease: Further Evidence of a Different Etiopathogenesis of Alexithymia and Depression 157
Diagnosi differenziale tra malattia da prioni e possibile variante di demenza fronto-temporale: un caso clinico 156
Updates on Somatoform Disorders (SFMD) in Parkinson's Disease and Dementia with Lewy Bodies and discussion of phenomenology. 155
L’EEG nel Mild Cognitive Impairment (MCI): valore predittivo per lo sviluppo di demenza a corpi di Lewy. 155
ALZHEIMER DISEASE AND LEWY BODY DEMENTIA CAN BE DISTINGUISHED BY THE CYTOMETRIC IDENTIFICATION OF A NOVEL DIAGNOSTIC BIOMARKER 152
Progetto atrofia multisistemica: risultati preliminari. 151
COMBINED REHABILITATION PROGRAM FOR POSTURAL INSTABILITY IN PROGRESSIVE SUPRANUCLEAR PALSY 151
Improving diagnostic accuracy of DLB: An MRI study 150
Structural alteration of the dorsal visual network in DLB patients with visual hallucinations: a cortical thickness MRI study 150
GABA content within medial prefrontal cortex predicts the variability of fronto-limbic effective connectivity 150
Bipallidal lesions induce delayed and progressive parkinsonism 149
Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences. 149
Abnormal BAEP and internal auditory canal MRI in intracranial hypotension 149
Amantadine and antiglutamatergic drugs in the management of Parkinson’s disease 149
A Critical Review of Alien Limb-Related Phenomena and Implications for Functional Magnetic Resonance Imaging Studies 149
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 148
Long half-life and prolonged-release receptor agonists:a review of ropinirole prolonged- release studies. 147
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 146
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 145
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 145
Attention network in AD and DLB patients: a resting fMRI study. 143
Autoscopic phenomena: case report and review of literature. 142
Monitoraggio in vivo, con Risonanza Magnetica Morfologica (MRI) e Spettroscopica (H-MRS), dei cambiamenti metabolici e morfologici sulla via nigro-striatale indotti dal trattamento con PSI in un modello animale di Parkinson 142
Cerebral venous thrombosis without thrombocytopenia after a single dose of COVID-19 (Ad26.COV2.S) vaccine injection: a case report 139
Structural connectivity is differently altered in dementia with Lewy body and Alzheimer’s disease 138
Eyelid retraction in dementia with Lewy Bodies and Parkinson’s Disease 137
Correlazione tra dinamica del repertorio TCR e reattività alla proteina basica della mielina (MBP) nel sangue periferico di pazienti con Sclerosi multipla esacerbante/remittente 137
Amygdala-vmPFC dysfunction as a marker of dementia in parkinsonism. 137
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 137
Instabilità posturale nel Parkinson non farmaco-responder 136
A stage-based approach to therapy in parkinson’s disease 136
Persistent genital arousal disorder associated with functional hyperconnectivity of an epileptic focus. 135
Cortical Activation During Levitation and Tentacular Movements of Corticobasal Syndrome 135
Manifestazioni ossessivo-compulsive nella Malattia di Parkinson. 132
Somatic symptoms disorders in Parkinson's disease are related to default mode and salience network dysfunction 132
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 132
A subtle mimicker in emergency department: Illustrated case reports of acute drug-induced dystonia 131
Cohort study on Somatoform Disorders in Parkinson’s Disease and Dementia with Lewy Bodies 130
Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency 129
Atrofia Multisistemica: approccio diagnostico multidisciplinare 129
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 129
Delayed blink reflex in dementia with Lewy bodies is sensitive to cholinergic modulation. 128
Morphological and Metabolic Changes in the Nigro-Striatal Pathway of Synthetic Proteasome Inhibitor (PSI)-Treated Rats: A MRI and MRS Study. 128
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 128
Catamenial end-off dose in Parkinson's disease 127
Different peripheral expression patterns of the nicotinic acetylcholine receptor in dementia with Lewy bodies and Alzheimer's disease 126
Pathological Gambling in PD is reduced by Amantadine 126
ECG monitoring of post-stroke occurring arrhythmias: an observational study using 7-day Holter ECG 126
"Occipital Pole" Sign on 18F-FDG PET for Dementia With Lewy Bodies and Posterior Cortical Atrophy: Evidence From the Treviso Dementia (TREDEM) Registry 126
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 125
Hallucinations, somatic-functional disorders of PD-DLB as expressions of thalamic dysfunction 125
Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders 125
Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel 125
Valutazione dei potenziali evocativi visivi durante terapia con farmaci antipsicotici atipici in pazienti con schizofrenia 124
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 124
Mitochondrial Involvement in Neurodegenerative Dementia 124
Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase 123
AMANTADINE EFFECT ON PARKINSON'S DISEASE IMPULSE CONTROL DISORDER 123
Regulation of Socs-1 and Gerp/TRIM-8 expression on multiple sclerosis patients undergoing interferon beta-1 treatment 123
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 123
Atrophy of hippocampal subfields and adjacent extrahippocampal structures in dementia with Lewy bodies and Alzheimer's disease 123
Decrease in a Leak Conductance Associated with Mitochondrial Complex V and Improved Bioenergetic Efficiency may Underlie Cytoprotection of at-Risk Neurons by Dexpramipexole 123
Brainstem evoked potentials and magnetic resonance imaging abnormalities in differential diagnosis of intracranial hypotension. 123
A signature pattern of cortical atrophy in dementia with Lewy bodies: A study on 333 patients from the European DLB consortium 123
Abnormalities of cortical neural synchronization mechanisms in patients with dementia due to Alzheimer's and Lewy body diseases: an EEG study 123
Serial analysis of peripheral blood T cell receptor (TCR) V beta repertoire by RT-PCR/SSCP in patients with multiple sclerosis (MS) and healthy controls. 122
Medio-dorsal thalamus and confabulations: Evidence from a clinical case and combined MRI/DTI study 122
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 121
RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-beta-1b 121
EEG IN PARKINSON'S DISEASE WITH DEMENTIA PREDICTS THE APPEARANCE OF FLUCTUATING COGNITION. XL Congresso SIN, Padova, novembre 2009. 121
Diabetes mellitus and amyotrophic lateral sclerosis: A systematic review 121
A multicentre validation study of the diagnostic value of plasma neurofilament light 121
Dynamics of peripheral blood T cell receptor V beta repertoire in patients with relapsing-remitting multiple sclerosis. 120
Extra-hippocampal alteration of grey matter in dementia with Lewy bodies and Alzheimer’s disease 120
The predictive power of transcranial sonography in movement disorders: a longitudinal cohort study 120
Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions 120
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 119
Totale 15.803
Salva come PNG Salva come JPEG
Categoria #
all - tutte 143.448
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 143.448
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202199 0 0 0 0 0 0 0 0 0 0 0 99
2021/20221.366 33 20 62 158 77 45 46 117 121 53 198 436
2022/20234.307 353 597 289 438 382 841 278 297 546 60 109 117
2023/20242.361 175 71 169 95 148 655 499 130 37 91 51 240
2024/20255.465 303 919 827 146 155 236 254 286 468 348 612 911
2025/202613.166 959 442 1.252 1.654 1.123 760 1.951 724 1.943 1.013 934 411
Totale 36.057